drugset
drugset / Trial / NCT04712838

Study on the Bioavailability of SHR0302 in Healthy Subjects

NCT04712838 ↗

Phase 1 Completed 24 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

The study is being conducted to evaluate the safety, and the relative bioavailability of SHR0302 tablets with three different formulations in healthy subjects.

Timeline

Start
2021-03-15
Primary completion
2021-04-13
Completion
2021-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR0302 Unknown — Oral

Indications

No indication recorded.